Furthermore, these cell lines express different combinations of oncogenes known to be important for neuroblastoma development and progression, such as amplified MYCN and mutated or amplified ALK (Cheung and Dyer, 2013; Emdal et al., 2018; Matthay et al., 2016) (Figure S1A). The gene discussed is MYCN; the disease is neuroblastoma.